Avanos Medical, Inc. (NYSE:AVNS - Get Free Report)'s share price reached a new 52-week low during mid-day trading on Tuesday . The company traded as low as $11.50 and last traded at $11.59, with a volume of 128089 shares. The stock had previously closed at $11.86.
Avanos Medical Stock Performance
The stock's 50-day moving average price is $12.35 and its 200-day moving average price is $13.90. The company has a current ratio of 2.57, a quick ratio of 1.56 and a debt-to-equity ratio of 0.12. The company has a market capitalization of $527.69 million, a P/E ratio of -1.36 and a beta of 1.12.
Avanos Medical (NYSE:AVNS - Get Free Report) last issued its quarterly earnings data on Tuesday, May 6th. The company reported $0.26 earnings per share for the quarter, beating the consensus estimate of $0.19 by $0.07. The firm had revenue of $167.50 million for the quarter, compared to the consensus estimate of $161.75 million. Avanos Medical had a negative net margin of 55.80% and a positive return on equity of 6.26%. Avanos Medical's quarterly revenue was up .8% compared to the same quarter last year. During the same period last year, the firm posted $0.22 EPS. As a group, equities analysts expect that Avanos Medical, Inc. will post 1.32 EPS for the current year.
Institutional Trading of Avanos Medical
Several hedge funds have recently bought and sold shares of AVNS. Quantbot Technologies LP bought a new stake in Avanos Medical in the 4th quarter valued at about $64,000. State of Wyoming increased its stake in Avanos Medical by 132.0% during the 4th quarter. State of Wyoming now owns 5,137 shares of the company's stock valued at $82,000 after buying an additional 2,923 shares during the period. Tower Research Capital LLC TRC increased its stake in Avanos Medical by 493.3% during the 4th quarter. Tower Research Capital LLC TRC now owns 8,075 shares of the company's stock valued at $129,000 after buying an additional 6,714 shares during the period. Heritage Family Offices LLP acquired a new position in Avanos Medical during the 1st quarter valued at about $146,000. Finally, EP Wealth Advisors LLC increased its stake in Avanos Medical by 14.6% during the 4th quarter. EP Wealth Advisors LLC now owns 10,108 shares of the company's stock valued at $161,000 after buying an additional 1,289 shares during the period. 95.17% of the stock is currently owned by institutional investors.
About Avanos Medical
(
Get Free Report)
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Featured Stories
Before you consider AVANOS MEDICAL, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AVANOS MEDICAL wasn't on the list.
While AVANOS MEDICAL currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
